The way that our society funds pharmaceutical research (by granting subsidized, temporary monopolies on any resulting products) seems completely incapable of re

The way that our society funds pharmaceutical research (by granting subsidized, temporary monopolies on any resulting products) seems completely incapable of responding to this sort of situation. A radically different incentive structure seems necessary...